Oxford BioDynamics invited to join FNIH steering committee

Josh White Sharecast | 20 Apr, 2017 16:48 | | |

Astrazeneca

Oxford Biodynamics

162.00

17:18 21/08/17
-0.31%
-0.50
  • 1,003.01
  • 0.37%3.72
  • Max: 1,004.63
  • Min: 998.42
  • Volume: 0
  • MM 200 : n/a
17:19 21/08/17

Discovery and development of novel epigenetic biomarkers-focussed biotechnology company Oxford BioDynamics announced on Thursday that itself and Dr Claudio Carini, a member of company’s scientific advisory panel, had been invited to join the Foundation for the National Institutes of Health Biomarkers Consortium as a member of the Cancer, Inflammation & Immunity, and Neuroscience Steering Committees.

The AIM-traded firm said the Biomarkers Consortium is a public-private biomedical research partnership managed by the FNIH that endeavours to discover, develop, and seek regulatory approval for biological markers, known as biomarkers, to support new drug development, precision medicine, and medical diagnostics.

It said the Steering Committees are responsible for identifying and moving forward promising pre-competitive biomarkers projects for implementation by The Biomarkers Consortium, as well as overseeing each individual project under its purview.

The members of each Steering Committee represent a variety of sectors, including academia, government, industry and not-for-profit and advocacy organisations, the board explained.

Dr Carini had prior experience as a member of the FNIH Biomarkers Consortium Steering Committees, as well as having consulted and sat on many other distinguished international advisory boards and committees including the Medical Research Council, Innovative Medicine Initiative and the PML Consortium, it added.

“We are delighted that Claudio will be joining these prestigious biomarker committees,” said Oxford BioDynamics CEO Christian Hoyer Millar.

“The FNIH Biomarkers Consortium aims to accelerate the development of biomarker-based technologies, medicines, and therapies for the prevention, early detection, diagnosis, and treatment of disease, and this is a goal that is shared by Oxford BioDynamics.

“We believe that becoming a member of these important FNIH committees will be beneficial as we continue to progress towards our strategic aim of becoming the industry standard for epigenetic biomarker discovery.”

More news

21 Aug US close: Markets mixed on light trading Monday

Wall Street finished mixed amid light volumes on Monday, as investors kept their wallets closed as both international tensions and domestic political turbulence put a dampener on sentiment.

21 Aug Europe close: Stocks down on euro gains, geopolitical angst

Stocks finished the day lower amid aggressive rhetoric out of North Korea as the US and South Korean militaries kicked-off their annual 10-day joint exercises and a bounce in the single currency's value.

21 Aug London close: Stocks flat ahead of Jackson Hole amid geopolitical nerves

London stocks ended on a mixed note at the start of the week as investors remained cautious amid geopolitical tensions.

21 Aug US open: Stocks flat ahead of Trump speech on Afghanistan

Wall Street was trading in mixed fashion ahead of a speech from the US president on Monday evening in which he was expected to outline his new strategy for the war in Afghanistan.

21 Aug Tuesday preview: Public deficit due, results from Persimmon, BHP, Cairn

The UK's public deficit gets its monthly update on Tuesday, along with the CBI's industrial trends survey and results from the likes of BHP Billiton, Cairn Energy, Persimmon and Wood Group.

21 Aug Luca Provolo appointed head of sales at Directa Plus

Graphene--based products producer and supplier Directa Plus announced the appointment of Luca Provolo as its head of sales on Monday, with effect from 4 September.

21 Aug Verditek subsidiary wins trial contract with Italian ad agency

Clean technology company Verditek announced on Monday that its 51% owned subsidiary Greenflex Energy - an Italian based manufacturing solar photovoltaic technology company - has won an initial trial contract with Media One - one of Italy's largest out of home advertising agencies - to supply and install its proprietary solar PV technology to power digital advertising billboards at outdoor bus shelters in Italy.

21 Aug FTSE 250 movers: Hikma boosted by upgrade, TBC higher on results

London's FTSE 250 was up 0.1% to 19,636.29 in afternoon trade.

21 Aug ITM Power welcomes launch of government hydrogen programme

Energy storage and clean fuel company ITM Power noted the launch of the UK Government's ‘Hydrogen for Transport Programme’ on Monday.

21 Aug Gfinity appointed esports partner to Formula 1

International esports group Gfinity announced on Monday that it has been appointed as esports partner for Formula 1, to deliver the Formula 1 ESports Series from September.